These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11144939)

  • 1. [AT1-blocker in heart failure. Patients are readmitted more infrequently to the clinic].
    MMW Fortschr Med; 2000 Nov; 142(48):4-5. PubMed ID: 11144939
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heart failure. With the AT1-blocker less frequent rehospitalization].
    MMW Fortschr Med; 2001 May; 143(20):65. PubMed ID: 11400619
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep; 144(35-36):57. PubMed ID: 12380364
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Tepper D
    Congest Heart Fail; 2002; 8(1):57-8. PubMed ID: 11821630
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heart failure. Who benefits from an AT1 blocker?].
    MMW Fortschr Med; 2001 Nov; 143(47):62. PubMed ID: 11791370
    [No Abstract]   [Full Text] [Related]  

  • 6. Valsartan in chronic heart failure.
    Haddy FJ
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11948282
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sartan as a new therapy option. When heart failure patients cannot tolerate an ACE inhibitor].
    MMW Fortschr Med; 2002 Oct; 144(40):49. PubMed ID: 12440300
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiotensin therapy: new perspectives.
    Ramasubbu K; Mann DL; Deswal A
    Cardiol Clin; 2007 Nov; 25(4):573-80; vi-vii. PubMed ID: 18063161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of AT1-angiotensin II receptor blocker valsartan in clinical practice].
    Maksimov ML; Mochkin IA; Starodubtsev AK
    Kardiologiia; 2011; 51(8):77-84. PubMed ID: 21942964
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.
    Mann DL; Deswal A
    N Engl J Med; 2003 Nov; 349(20):1963-5. PubMed ID: 14610159
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of ARB and ACE inhibitors in heart failure patients.
    Wexler R; Feldman D
    Am Fam Physician; 2009 Mar; 79(6):454; author reply 456. PubMed ID: 19323357
    [No Abstract]   [Full Text] [Related]  

  • 14. Valsartan in chronic heart failure.
    Campbell DJ
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951863
    [No Abstract]   [Full Text] [Related]  

  • 15. Valsartan in chronic heart failure.
    Cayley WE
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951861
    [No Abstract]   [Full Text] [Related]  

  • 16. Valsartan in chronic heart failure.
    Forfar JC; Munir S
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951862
    [No Abstract]   [Full Text] [Related]  

  • 17. [ESC guidelines for therapy of heart failure. AT1 blockers are now also included].
    MMW Fortschr Med; 2002 Jan; 144(3-4):62. PubMed ID: 11862800
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fixed combination of AT1 blocker and diuretic. Stroke preventive combination for hypertension].
    MMW Fortschr Med; 2002 Jul; 144(27-28):59. PubMed ID: 12198887
    [No Abstract]   [Full Text] [Related]  

  • 19. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
    MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
    [No Abstract]   [Full Text] [Related]  

  • 20. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M
    Heart Fail Monit; 2002; 2(3):85-7. PubMed ID: 12634889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.